´ëÇÑ´ç´¢º´ÇÐȸ 2022 ´ë»çÁúȯ ½Å¾à ¹× ±â¼ú°³¹ß ½ÉÆ÷Áö¾ö : 2022-10-21±³À°ÀÏÀÚ : 2022-10-21
±³À°Àå¼Ò : ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼BȦ
±³À°ÁÖÁ¦ :
2022 ´ë»çÁúȯ ½Å¾à ¹× ±â¼ú°³¹ß ½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ
´ã´çÀÚ : À¯ÁöÀÎ
¿¬¶ôó : 02-714-9072
À̸ÞÀÏ :
diabetes@kams.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
´ë±¸±¤¿ª½Ã±³À°½Ã°£ : 4 ½Ã°£ 15ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 10-21 13:00~13:10 Àλ縻 ()
±³À°½Ã°£ 10-21 13:10~13:40 ´ë»çÁúȯ°ú single cell sequencingÀÇ Àû¿ë°ú ¹Ì·¡ ±è¼¼¿ø(·ÎŶÁ¦³ë¹Í½º ´ëÇ¥ÀÌ»ç)
±³À°½Ã°£ 10-21 13:40~14:10 Beneficial Effects of a Curcumin Derivative and Transforming Growth Factor-¥â Receptor I Inhibitor Combination on Nonalcoholic Steatohepatitis ÇÏ°æºÀ(¿¬¼¼¿øÁÖÀÇ´ë)
±³À°½Ã°£ 10-21 14:10~14:40 ¹ÝÀÀ¼º ±³¼¼Æ÷ Á¶Àý ½Å±Ô ¾ËÃ÷ÇÏÀ̸Ӻ´ Ä¡·áÁ¦ °³¹ß ¹Ú±â´ö(KIST)
Åä·Ð 10-21 14:40~14:55 ÆгÎÅäÀÇ ÀÌÀ縸, Á¶µÎÇü, ¹Ú¼Ò¿µ(°æºÏÀÇ´ë, ¿µ³²ÀÇ´ë, ¿µ³²ÀÇ´ë)
±³À°½Ã°£ 10-21 14:55~15:15 Çѱ¹ÀÎ ºÎ½ÅÈ£¸£¸ó ÂüÁ¶Ç¥ÁØ È®¸³À» À§ÇÑ ¿¬±¸ ±èÈ¿Á¤(À»ÁöÀÇ´ë)
±³À°½Ã°£ 10-21 15:15~15:35 Harmonization of C-peptide assays Á¶ÁÖ¿µ(¿¬¼¼¿øÁÖÀÇ´ë)
±³À°½Ã°£ 10-21 15:35~15:55 ³²¼ºÈ£¸£¸óÀÇ ÃøÁ¤°ú ³²¼º°»³â±âÀÇ Áø´Ü ÀÌÁØÈ£(À»ÁöÀÇ´ë)
Åä·Ð 10-21 15:55~16:10 ÆгÎÅäÀÇ ³²±ÃÀϼº, ·ù¿ÁÇö, ±èÇö±â(¿ï»êÀÇ´ë, ÇѸ²ÀÇ´ë, Çѱ¹ÀüÀÚÁ¤º¸Åë½Å»ê¾÷ÁøÈïȸ)
ÈÞ½Ä 10-21 16:10~16:25 Break time ()
±³À°½Ã°£ 10-21 16:25~16:45 miRNA¿Í ´ç´ë»ç ¹ÙÀÌ¿À¸¶Ä¿(°¡Á¦¸ñ) Á¶³Èñ(°è¸íÀÇ´ë)
±³À°½Ã°£ 10-21 16:45~17:05 ´ë»çÁúȯ ¹ÙÀÌ¿À ¸¶Ä¿ ÃøÁ¤À» À§ÇÑ ¹ÙÀÌ¿À ¼¾¼ ÇãÀ±¼®(°è¸íÀÇ´ë)
±³À°½Ã°£ 10-21 17:05~17:25 SREBP-1c deficiency ameliorates hepatic steatosis and liver fibrosis in NASH Àӽ¼ø(°è¸íÀÇ´ë)
Åä·Ð 10-21 17:25~17:40 ÆгÎÅäÀÇ Á¶È£Âù, ±¸Ã¶·æ, ¹ÚÀçÇü, À¯ÁöÈ«(°è¸íÀÇ´ë, ¿¬¼¼ÀÇ´ë, °è¸íÀÇ´ë, °è¸íÀÇ´ë)